What's New on the FDA Drugs Site
June 8, 2017
- Oxymorphone (marketed as Opana ER) Information
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Approval Package: Tymlos Subcutaneous Injection
- Drug Trials Snapshots: KEVZARA
- National Drug Code Directory: Download the New NDC Express Mobile Application
- Updated Process for Qualification of Drug Development Tools Under New FD&C Act Section 507
- Phonetic and Orthographic Computer Analysis (POCA) program (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario